ArticleCancer reports (Hoboken, N.J.)2024

Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma: Insights from real-life clinical practice.

Jasmine Mohamad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.